Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bertheau

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiencyR Cohen, O Buhard, P Cervera, et al.
Breast (Edinburgh, Scotland)|October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trialF Valet, P de Cremoux, F Spyratos, et al.
British Journal of Cancer|May 5, 2011
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approachesJ Lehmann-Che, F Amira-Bouhidel, E Turpin, et al.
Oncogene|July 26, 2011
A refined molecular taxonomy of breast cancerM Guedj, L Marisa, A de Reynies, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2017
Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiencyR Cohen, O Buhard, P Cervera, et al.
Breast (Edinburgh, Scotland)|October 8, 2013
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trialF Valet, P de Cremoux, F Spyratos, et al.
British Journal of Cancer|May 5, 2011
Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approachesJ Lehmann-Che, F Amira-Bouhidel, E Turpin, et al.
Oncogene|July 26, 2011
A refined molecular taxonomy of breast cancerM Guedj, L Marisa, A de Reynies, et al.
Pageof 5